Matches in Wikidata for { <http://www.wikidata.org/entity/Q54978260> ?p ?o ?g. }
- Q54978260 description "2018 nî lūn-bûn" @default.
- Q54978260 description "2018年の論文" @default.
- Q54978260 description "2018年学术文章" @default.
- Q54978260 description "2018年学术文章" @default.
- Q54978260 description "2018年学术文章" @default.
- Q54978260 description "2018年学术文章" @default.
- Q54978260 description "2018年学术文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018年學術文章" @default.
- Q54978260 description "2018년 논문" @default.
- Q54978260 description "article científic" @default.
- Q54978260 description "article scientific" @default.
- Q54978260 description "article scientifique (publié 2018)" @default.
- Q54978260 description "articol științific" @default.
- Q54978260 description "articolo scientifico" @default.
- Q54978260 description "artigo científico (publicado na 2018)" @default.
- Q54978260 description "artigo científico (publicado na 2018)" @default.
- Q54978260 description "artigo científico" @default.
- Q54978260 description "artikull shkencor" @default.
- Q54978260 description "artikulong pang-agham" @default.
- Q54978260 description "artykuł naukowy" @default.
- Q54978260 description "artículo científico publicado en 2018" @default.
- Q54978260 description "artículu científicu" @default.
- Q54978260 description "bilimsel makale" @default.
- Q54978260 description "bài báo khoa học" @default.
- Q54978260 description "mokslinis straipsnis" @default.
- Q54978260 description "naučni članak" @default.
- Q54978260 description "scienca artikolo" @default.
- Q54978260 description "scientific article" @default.
- Q54978260 description "teaduslik artikkel" @default.
- Q54978260 description "tieteellinen artikkeli" @default.
- Q54978260 description "tudományos cikk" @default.
- Q54978260 description "vedecký článok" @default.
- Q54978260 description "vetenskaplig artikel" @default.
- Q54978260 description "videnskabelig artikel (udgivet 2018)" @default.
- Q54978260 description "vitenskapelig artikkel" @default.
- Q54978260 description "vitskapeleg artikkel" @default.
- Q54978260 description "vědecký článek" @default.
- Q54978260 description "wetenschappelijk artikel" @default.
- Q54978260 description "wissenschaftlicher Artikel" @default.
- Q54978260 description "επιστημονικό άρθρο" @default.
- Q54978260 description "мақолаи илмӣ" @default.
- Q54978260 description "мақолаи илмӣ" @default.
- Q54978260 description "наукова стаття, опублікована в червні 2018" @default.
- Q54978260 description "научна статия" @default.
- Q54978260 description "научная статья" @default.
- Q54978260 description "научни чланак" @default.
- Q54978260 description "научни чланак" @default.
- Q54978260 description "գիտական հոդված" @default.
- Q54978260 description "מאמר מדעי" @default.
- Q54978260 description "سائنسی مضمون" @default.
- Q54978260 description "مقالة علمية" @default.
- Q54978260 description "مقالهٔ علمی" @default.
- Q54978260 description "২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q54978260 description "บทความทางวิทยาศาสตร์" @default.
- Q54978260 description "სამეცნიერო სტატია" @default.
- Q54978260 name "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 name "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 type Item @default.
- Q54978260 label "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 label "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 prefLabel "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 prefLabel "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 P1433 Q54978260-B8328DC3-8EA6-4B7C-96E7-DA0E1E38B588 @default.
- Q54978260 P1476 Q54978260-5E560FF8-62B3-4D08-9672-67AEA0FC95F8 @default.
- Q54978260 P2093 Q54978260-10BEA465-AD8F-4139-94A8-3AE9D6F91485 @default.
- Q54978260 P2093 Q54978260-4F90EC1E-F198-4B04-B0CA-0CB42B27BF0B @default.
- Q54978260 P2093 Q54978260-5B9B73D9-DA80-49DE-B595-DAAB7B166433 @default.
- Q54978260 P2093 Q54978260-80EA9A0D-DEF0-402C-94B4-F4DFEE0418CF @default.
- Q54978260 P2093 Q54978260-9FC5FC15-3E73-46C3-A8A8-F4AD77902895 @default.
- Q54978260 P2093 Q54978260-A4A65913-3CA5-4EF9-A219-2BE85D522F05 @default.
- Q54978260 P2093 Q54978260-C34A0C31-A8BA-4A75-AB83-4104ABF17286 @default.
- Q54978260 P2093 Q54978260-C56FC9C5-2A0A-410E-86A5-60C33AC75847 @default.
- Q54978260 P2093 Q54978260-C96A2E73-29A5-475B-89E9-BB955372CB8E @default.
- Q54978260 P2093 Q54978260-C9D55885-EA32-4BF6-B8B3-E3C17CBC12EF @default.
- Q54978260 P2093 Q54978260-CC5F7085-850D-4812-806D-34238E37BE8D @default.
- Q54978260 P2093 Q54978260-FE427156-0562-4D5F-A00C-C346F7FA7DDD @default.
- Q54978260 P304 Q54978260-150F28E1-F135-49B4-9431-2AC44F115936 @default.
- Q54978260 P31 Q54978260-5DF94031-93C6-4AD4-8828-BA747EDB8A95 @default.
- Q54978260 P356 Q54978260-5D5BA0E5-DE54-4C75-AFDF-9C649C9E0D16 @default.
- Q54978260 P433 Q54978260-E635896F-E49E-4A7F-AF03-8840B977D477 @default.
- Q54978260 P478 Q54978260-B49B0025-89CF-48BA-BA50-1056363BECCF @default.
- Q54978260 P577 Q54978260-CA2A7BF8-711E-42DE-8EAD-C7312DECDD19 @default.
- Q54978260 P698 Q54978260-40B8FD29-BA94-4BF7-B448-361790410613 @default.
- Q54978260 P921 Q54978260-964A7450-8493-48FF-8D0C-F9B3B1160F96 @default.
- Q54978260 P356 JMCP.2018.24.6.514 @default.
- Q54978260 P698 29799329 @default.
- Q54978260 P1433 Q23894211 @default.
- Q54978260 P1476 "Cost-Effectiveness of Ribociclib plus Letrozole Versus Palbociclib plus Letrozole and Letrozole Monotherapy in the First-Line Treatment of Postmenopausal Women with HR+/HER2- Advanced or Metastatic Breast Cancer: A U.S. Payer Perspective." @default.
- Q54978260 P2093 "Anand A Dalal" @default.
- Q54978260 P2093 "Derek Tang" @default.
- Q54978260 P2093 "Devarshi Bhattacharyya" @default.
- Q54978260 P2093 "Diana Brixner" @default.
- Q54978260 P2093 "Dinesh Mishra" @default.
- Q54978260 P2093 "Gary Oderda" @default.
- Q54978260 P2093 "Gaurav Suri" @default.